Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colpistatin 5DT in Vaginal Discharge
NCT02713139Phase 3Withdrawn
- Sponsor
- Aché Laboratórios Farmacêuticos
- Start
- Sep 2013
- Primary completion
- Mar 2014
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of Clotrimazole Vaginal Spray and metronidazole in vaginal discharge (3 arms), sponsored by Aché Laboratórios Farmacêuticos. Primary endpoint: Ceasing of the symptoms of vaginal discharge. Planned start Sep 2013; status: withdrawn.
02
Drugs
Clotrimazole Vaginal Spraymetronidazole
03
Conditions
vaginal discharge
Beyond the preview
Go deeper on NCT02713139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02713139.